Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 27.938% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCC1C(=O)NCCN1Cc1nc(-c2ccc(C)s2)oc1C
(b) COc1ccc(Br)cc1C(=O)Nc1ccc(C(=O)O)cc1
(c) Cc1cc(Cc2ccc(N)c(C)c2)ccc1N
Answer: a. CCC1C(=O)NCCN1Cc1nc(-c2ccc(C)s2)oc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1C(=O)NCCN1Cc1nc(-c2ccc(C)s2)oc1C
CCC1C(=O)NCCN1Cc1nc(-c2ccc(C)s2)oc1C
3-ethyl-4-[[5-methyl-2-(5-methylthiophen-2-yl)-1,3-oxazol-4-yl]methyl]piperazin-2-one